Instem Stock

Instem EBIT

Delisted·Nov 20, 2023

The EBIT of Instem (INS.L) as of Aug 10, 2026 is 6.50 M GBP. In the previous year, EBIT was 4.77 M GBP — a change of 36.21% (higher).

EBIT

6.50 MGBP

YoY

36.21%

Last updated:

In 2026, Instem's EBIT was 6.50 M GBP, a 36.21% increase from the 4.77 M GBP EBIT recorded in the previous year.

The Instem EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M GBP)
Date
EBIT (M GBP)
Jan 1, 2019
2.83 base
Jan 1, 2020
3.81 base
Jan 1, 2021
4.77 base
Jan 1, 2022
6.50 base
Jan 1, 2023 (e)
9.06 base
Jan 1, 2024 (e)
11.54 base
Jan 1, 2025 (e)
6.52 base
Jan 1, 2026 (e)
21.27 base
YEAREBIT (M GBP)
2026 est 21.27
2025 est 6.52
2024 est 11.54
2023 est 9.06
2022 6.50
2021 4.77
2020 3.81
2019 2.83
2018 2.38
2017 0.82
2016 0.05
2015 1.34
2014 0.68
2013 0.96
2012 1.02
2011 1.57
2010 2.20
2009 2.14
2008 1.91
2007 1.77
Access this data via the Eulerpool API

Instem Revenue

Instem Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
25.72 M GBP
2.83 M GBP
-920,000.00 GBP
Jan 1, 2020
28.22 M GBP
3.81 M GBP
2.27 M GBP
Jan 1, 2021
46.02 M GBP
4.77 M GBP
1.68 M GBP
Jan 1, 2022
57.63 M GBP
6.50 M GBP
4.70 M GBP
Jan 1, 2023 (e)
67.21 M GBP
9.06 M GBP
7.27 M GBP
Jan 1, 2024 (e)
75.86 M GBP
11.54 M GBP
9.18 M GBP
Jan 1, 2025 (e)
81.64 M GBP
6.52 M GBP
9.07 M GBP
Jan 1, 2026 (e)
90.28 M GBP
21.27 M GBP
13.48 M GBP

Instem Margins

Instem stock margins

The Instem margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Instem. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Instem.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
94.32 %
11.00 %
-3.58 %
Jan 1, 2020
94.51 %
13.50 %
8.04 %
Jan 1, 2021
96.26 %
10.37 %
3.65 %
Jan 1, 2022
96.26 %
11.27 %
8.15 %
Jan 1, 2023 (e)
96.26 %
13.49 %
10.81 %
Jan 1, 2024 (e)
96.26 %
15.21 %
12.10 %
Jan 1, 2025 (e)
96.26 %
7.99 %
11.11 %
Jan 1, 2026 (e)
96.26 %
23.56 %
14.93 %

Instem Stock analysis

What does Instem do? Instem PLC is a company specialized in providing software solutions for the health and life sciences. It is headquartered in Abingdon, Oxfordshire and operates internationally. The company was founded in 2000 and has been listed on the London Stock Exchange since 2004. Instem's business model is based on helping life science companies optimize and automate their workflows. They offer a wide range of software products tailored to the specific needs of their customers. This includes systems for documenting animal experiments, clinical data collection, and solutions for regulatory drug submissions. One of Instem's key divisions is the Preclinical Solutions Division, which helps life science companies effectively plan and conduct their preclinical studies. The products in this division support the creation of study protocols, planning experimental procedures, and documenting study results. Additionally, customers of the Preclinical Solutions Division can access assistance with data collection and analysis, as well as comprehensive consulting services. Another important division of Instem is the Clinical Solutions Division, which supports clinical research facilities in conducting clinical trials. Their solutions include clinical data collection, study monitoring, and data submission to regulatory authorities. The Clinical Solutions Division also provides support for quality control and the production of statistical reports. Instem is also active in other areas, such as in vitro diagnostics and chemical approval. In these fields, the company offers a range of software solutions that aid in data collection, analysis, and reporting. A key factor that sets Instem apart from its competitors is its close collaboration with the life science community. The company works closely with customers, regulatory agencies, and interest groups to ensure that its products meet industry requirements and standards. In addition, the company has established close relationships with leading clinical and research institutions worldwide. In summary, Instem PLC is a significant provider of software solutions for the health and life sciences. The company has experienced impressive growth in recent years and strengthened its position in key market segments. Instem is well positioned to continue benefiting from the increasing demand for software solutions in the health and life sciences industry. Instem is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Instem's EBIT

Instem's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Instem's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Instem's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Instem’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Instem stock

EBIT of Instem is 6.50 M GBP in 2026.

EBIT of Instem changed from 4.77 M GBP to 6.50 M GBP, representing a 36.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Instem since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's GBP is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Instem historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Instem

All Key Metrics — Instem